(Q34940205)
Statements
1 reference
U.S. Food and Drug Administration perspective of the inclusion of effects of low-level exposures in safety and risk assessment (English)
1 reference
Gaylor DW
1 reference
Bolger PM
1 reference
Schwetz BA
1 reference
1 February 1998
5 references
18 June 2019
19 September 2019
28 September 2019
17 October 2020
5 references
18 June 2019
19 September 2019
28 September 2019
17 October 2020
106 Suppl 1
1 reference
391-394
1 reference
Identifiers
1 reference
1 reference